ArticleCureus2025
Ewing's Sarcoma of the Prostate Presenting as Back Pain: A Report of a Rare Case and Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ewing's sarcoma is an aggressive small round blue cell tumor typically arising in bone or soft tissues of children and young adults. Primary involvement of the prostate is exceptionally rare, with only a handful of cases reported. The unusual site and nonspecific clinical presentation often delay diagnosis. We report the case of a 35-year-old male patient who initially presented with progressive lower back pain of two months' duration, without neurological deficits. The pain was accompanied by urinary hesitancy and abdominal discomfort. Imaging revealed a markedly enlarged prostate (13.2 × 11.1 × 18.1 cm) with heterogeneous enhancement, cystic degeneration, and compression of adjacent pelvic structures. PET-CT demonstrated intense fluorodeoxyglucose (FDG) uptake in the prostate and distant metastases involving the lungs and liver. Histopathology of a core biopsy showed sheets of small round blue cells with hyperchromatic nuclei and scant cytoplasm, along with rosette formation. Immunohistochemistry (IHC) was positive for CD99, FLI-1, and NKX2.2, with a high Ki-67 proliferative index (80%). Fluorescence in situ hybridization (FISH) confirmed an EWSR1 gene rearrangement, establishing the diagnosis of Ewing's sarcoma of the prostate. The patient was started on multimodality VAC-IE (vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and etoposide) chemotherapy. Given the presence of systemic metastases at diagnosis, the prognosis remains guarded, but early initiation of therapy was pursued to achieve disease control. This case underscores the diagnostic challenge of Ewing's sarcoma in an unusual site such as the prostate, particularly when presenting with back pain rather than urological complaints. Persistent or unexplained back pain in young adults should prompt consideration of rare malignancies. Comprehensive imaging, histopathology, IHC, and molecular analysis remain indispensable for diagnosis. Early recognition and a multidisciplinary treatment approach are essential to improving outcomes in this aggressive disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.